Search

Gibson, R S, and A B Kimball. 2021. “Refining How We Measure As We Test: New Insights Using Adalimumab in Patients With Hidradenitis Suppurativa.”. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (12): 2342.

Flood, Kelsey S, Martina L Porter, and Alexa B Kimball. 2021. “A Visit Guide for Hidradenitis Suppurativa-Managing a Complex Disease in a Busy Clinic.”. Journal of the American Academy of Dermatology 84 (3): e155-e160.

Mehdizadeh, Ali, Afsaneh Alavi, Raed Alhusayen, Boris Bauer, Falk G Bechara, Marc Bourcier, Alain Brassard, et al. 2018. “Proceeding Report of the Symposium on Hidradenitis Suppurativa Advances (SHSA).”. Experimental Dermatology 27 (1): 104-12.

Zouboulis, C C, T Tzellos, A Kyrgidis, G B E Jemec, F G Bechara, E J Giamarellos-Bourboulis, J R Ingram, et al. 2017. “Development and Validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a Novel Dynamic Scoring System to Assess HS Severity.”. The British Journal of Dermatology 177 (5): 1401-9.

Danesh, Melissa J, and Alexa Boer Kimball. 2015. “Pyrithione Zinc As a General Management Strategy for Hidradenitis Suppurativa.”. Journal of the American Academy of Dermatology 73 (5): e175.

Kimball, A B, G B E Jemec, M Yang, A Kageleiry, J E Signorovitch, M M Okun, Y Gu, K Wang, P Mulani, and M Sundaram. 2014. “Assessing the Validity, Responsiveness and Meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) As the Clinical Endpoint for Hidradenitis Suppurativa Treatment.”. The British Journal of Dermatology 171 (6): 1434-42.

Kim, G E, J Shlyankevich, and A B Kimball. 2014. “The Validity of the Diagnostic Code for Hidradenitis Suppurativa in an Electronic Database.”. The British Journal of Dermatology 171 (2): 338-42.

Kimball, Alexa B, Yihua Gu, and Martin Okun. 2013. “Treatment of Moderate to Severe Hidradenitis Suppurativa.”. Annals of Internal Medicine 159 (1): 72-3.

Kimball, Alexa B, Dimittri Delevry, Min Yang, Chien-Chia Chuang, Zhixiao Wang, Gaëlle Bégo-Le-Bagousse, Bruno Martins, et al. 2023. “Long-Term Effectiveness of Dupilumab in Patients With Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.”. Dermatology and Therapy 13 (9): 2107-20.

Li, Hao, Maria G Tsokos, Rhea Bhargava, Iannis E Adamopoulos, Hanni Menn-Josephy, Isaac E Stillman, Philip Rosenstiel, Jarrat Jordan, and George C Tsokos. 2021. “IL-23 Reshapes Kidney Resident Cell Metabolism and Promotes Local Kidney Inflammation.”. The Journal of Clinical Investigation 131 (12).